⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iiib primary peritoneal cancer

Every month we try and update this database with for stage iiib primary peritoneal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or RecurrentNCT02470559
Malignant Ovari...
Malignant Ovari...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Aldesleukin
HER2Bi-Armed Ac...
Laboratory Biom...
Sargramostim
18 Years - Barbara Ann Karmanos Cancer Institute
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerNCT01010126
Adult Hepatocel...
Advanced Adult ...
Endometrial Ser...
Localized Non-R...
Lung Carcinoid ...
Malignant Pancr...
Malignant Pancr...
Malignant Pancr...
Malignant Pancr...
Metastatic Dige...
Ovarian Carcino...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Pancreatic Alph...
Pancreatic Beta...
Pancreatic Delt...
Pancreatic G-Ce...
Pancreatic Poly...
Recurrent Adult...
Recurrent Diges...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prima...
Recurrent Uteri...
Regional Digest...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Uteri...
Stage IVB Uteri...
Uterine Carcino...
Bevacizumab
Temsirolimus
18 Years - National Cancer Institute (NCI)
Collecting Tumor Samples From Patients With Gynecological TumorsNCT00897442
Borderline Ovar...
Borderline Ovar...
Cervical Adenoc...
Cervical Adenos...
Cervical Small ...
Cervical Squamo...
Childhood Embry...
Childhood Malig...
Endometrioid St...
Gestational Tro...
Malignant Mesot...
Malignant Ovari...
Melanoma
Neoplasm of Unc...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Serous ...
Paget Disease o...
Recurrent Cervi...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Recurrent Vagin...
Recurrent Vulva...
Stage I Ovarian...
Stage I Uterine...
Stage I Vaginal...
Stage I Vulvar ...
Stage IA Cervic...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IB Cervic...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage II Ovaria...
Stage II Uterin...
Stage II Vagina...
Stage II Vulvar...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage III Borde...
Stage III Cervi...
Stage III Uteri...
Stage III Vagin...
Stage III Vulva...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Border...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Vagin...
Stage IVB Vulva...
Uterine Corpus ...
Uterine Corpus ...
Vulvar Squamous...
Laboratory Biom...
- GOG Foundation
IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryNCT03029611
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Carboplatin
Gynecological S...
Laboratory Biom...
Paclitaxel
pUMVC3-hIGFBP-2...
18 Years - University of Washington
Collecting Tumor Samples From Patients With Gynecological TumorsNCT00897442
Borderline Ovar...
Borderline Ovar...
Cervical Adenoc...
Cervical Adenos...
Cervical Small ...
Cervical Squamo...
Childhood Embry...
Childhood Malig...
Endometrioid St...
Gestational Tro...
Malignant Mesot...
Malignant Ovari...
Melanoma
Neoplasm of Unc...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Serous ...
Paget Disease o...
Recurrent Cervi...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Recurrent Vagin...
Recurrent Vulva...
Stage I Ovarian...
Stage I Uterine...
Stage I Vaginal...
Stage I Vulvar ...
Stage IA Cervic...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IB Cervic...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage II Ovaria...
Stage II Uterin...
Stage II Vagina...
Stage II Vulvar...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage III Borde...
Stage III Cervi...
Stage III Uteri...
Stage III Vagin...
Stage III Vulva...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Border...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Vagin...
Stage IVB Vulva...
Uterine Corpus ...
Uterine Corpus ...
Vulvar Squamous...
Laboratory Biom...
- GOG Foundation
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerNCT00262847
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Bevacizumab
Carboplatin
Laboratory Biom...
Paclitaxel
Placebo
Quality-of-Life...
18 Years - National Cancer Institute (NCI)
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete RemissionNCT00857545
Stage IA Fallop...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Laboratory Biom...
Polyvalent Anti...
Saponin-based I...
18 Years - GOG Foundation
IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryNCT03029611
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Carboplatin
Gynecological S...
Laboratory Biom...
Paclitaxel
pUMVC3-hIGFBP-2...
18 Years - University of Washington
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerNCT02311907
Chemotherapeuti...
Neuropathy
Neurotoxicity S...
Pain
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Carboplatin
Glutathione
Laboratory Biom...
Paclitaxel
Placebo
Quality-of-Life...
18 Years - Alliance for Clinical Trials in Oncology
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT01606241
Recurrent Breas...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage IIA Breas...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Breas...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Brea...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Brea...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Brea...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Cyclophosphamid...
Laboratory Biom...
Multi-epitope F...
18 Years - Mayo Clinic
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyNCT00899093
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Ovarian Adenoca...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Cytology Specim...
Laboratory Biom...
18 Years - GOG Foundation
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyNCT01080521
Cognitive Side ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Carcino...
Ovarian Chorioc...
Ovarian Clear C...
Ovarian Dysgerm...
Ovarian Embryon...
Ovarian Endomet...
Ovarian Mixed G...
Ovarian Mucinou...
Ovarian Polyemb...
Ovarian Sarcoma
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Teratom...
Ovarian Yolk Sa...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Cognitive Asses...
Quality-of-Life...
18 Years - GOG Foundation
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02833506
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Laboratory Biom...
Recombinant NY-...
Sirolimus
18 Years - Roswell Park Cancer Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: